Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Krause

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry|April 1, 1997
Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agentsT S Purchase, A D Essenburg, K L Hamelehle, et al.
Journal of Medicinal Chemistry|March 15, 1996
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 17. Structure-activity relationships of several series of compounds derived from N-chlorosulfonyl isocyanateJ A Picard, P M O'Brien, D R Sliskovic, et al.
Journal of Medicinal Chemistry|June 10, 1994
Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivoP M O'Brien, D R Sliskovic, C J Blankley, et al.
Journal of Medicinal Chemistry|July 22, 1994
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 11. Structure-activity relationships of several series of compounds derived from N-(chlorocarbonyl) isocyanateJ A Picard, R F Bousley, H T Lee, et al.
Journal of Medicinal Chemistry|January 1, 1991
Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitorsD R Sliskovic, J A Picard, W H Roark, et al.
Atherosclerosis|November 15, 1996
Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic ratsB R Krause, B C Barnett, A D Essenburg, et al.
Bioorganic & Medicinal Chemistry|January 1, 1995
Bioisosterism in drug design: identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitorsW H Roark, J Padia, G L Bolton, et al.
Biochimica Et Biophysica Acta|January 24, 1992
Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitorsT M Bocan, E Ferguson, W McNally, et al.
Journal of Medicinal Chemistry|May 27, 1994
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activityB K Trivedi, T S Purchase, A Holmes, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidatesH T Lee, W H Roark, J A Picard, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|April 1, 1997
Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agentsT S Purchase, A D Essenburg, K L Hamelehle, et al.
Journal of Medicinal Chemistry|March 15, 1996
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 17. Structure-activity relationships of several series of compounds derived from N-chlorosulfonyl isocyanateJ A Picard, P M O'Brien, D R Sliskovic, et al.
Journal of Medicinal Chemistry|June 10, 1994
Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivoP M O'Brien, D R Sliskovic, C J Blankley, et al.
Journal of Medicinal Chemistry|July 22, 1994
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 11. Structure-activity relationships of several series of compounds derived from N-(chlorocarbonyl) isocyanateJ A Picard, R F Bousley, H T Lee, et al.
Journal of Medicinal Chemistry|January 1, 1991
Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitorsD R Sliskovic, J A Picard, W H Roark, et al.
Atherosclerosis|November 15, 1996
Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic ratsB R Krause, B C Barnett, A D Essenburg, et al.
Bioorganic & Medicinal Chemistry|January 1, 1995
Bioisosterism in drug design: identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitorsW H Roark, J Padia, G L Bolton, et al.
Biochimica Et Biophysica Acta|January 24, 1992
Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitorsT M Bocan, E Ferguson, W McNally, et al.
Journal of Medicinal Chemistry|May 27, 1994
Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activityB K Trivedi, T S Purchase, A Holmes, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT) as hypocholesterolemic agents: synthesis and structure-activity relationships of novel series of sulfonamides, acylphosphonamides and acylphosphoramidatesH T Lee, W H Roark, J A Picard, et al.
Pageof 6